Lichen planus (LP) is a chronic inflammatory mucocutaneous disease. The inflammatory
status of LP may be related to S100A8 (myeloid-related protein 8; MRP8) activation of …

Recent studies have noticed significant role of interleukin (IL)-17, 22, 23, Foxp3, interferon-
gamma (IFN-γ) and Wnt5a in oral and cutaneous lichen planus (LP). This study was …

S100A8, a calcium binding protein, is associated with keratinocyte differentiation,
inflammation and wound healing. High expression of S100A8 has been found in …

Background: Lichen planus (LP) is a chronic autoimmune inflammatory mucocutaneous
disease. Interleukin (IL)-17 is the signature cytokine of T-helper 17 cells, involved in the …

Background Lichen sclerosus (LS) is a chronic inflammatory skin condition. The recent
demonstration of circulating autoantibodies to extracellular matrix protein 1 and to basement …

Atopic dermatitis (AD) is an inflammatory skin disorder caused by immunological
dysregulation and genetic factors. Whether the expression levels of cytokine and skin barrier …

Background Lichen planus (LP) is a chronic autoimmune disease with different clinical
subtypes including cutaneous LP (CLP) and oral LP (OLP). We aimed to compare mRNA …

Atopic dermatitis (AD) is an inflammatory skin disease associated with frequent skin infection
and impaired skin barrier function. Recent studies indicate that increased Th2 cytokine …

Psoriasis is a chronic inflammatory skin disorder driven by the IL-23/type 3 immune
response. However, molecular mechanisms sustaining the chronicity of inflammation and …

Background Lichen planus (LP) is an autoinflammatory mucocutaneous skin disorder with a
multifactorial pathogenesis. Squamous cell carcinoma antigen (SCCA) is a tumor marker …